39 results
PRE 14A
GOSS
Gossamer Bio Inc
17 Apr 23
Preliminary proxy
4:01pm
goals and objectives relevant to the compensation of our Chief Executive Officer and other executive officers, evaluates the performance of these officers … in light of those goals and objectives and approves the compensation of these officers based on such evaluations. The compensation committee also
8-K
EX-10.1
56z5x zpd9kdfucz6qb
27 Nov 23
Departure of Directors or Certain Officers
4:01pm
S-1
EX-10.5
caeyjq bjcm4uj
21 Dec 18
IPO registration
4:39pm
8-K
EX-99.1
ivdknff
24 Mar 20
Gossamer Bio Announces Fourth Quarter and Full-Year 2019 Financial Results and Provides Business Update
8:45am
S-1/A
EX-10.5
jyrhwu64flj8b jr20z
23 Jan 19
IPO registration (amended)
4:39pm
8-K
EX-99.2
yn7j20 qw74r
13 Oct 20
Gossamer Bio Announces Topline Results for Phase 2 Trials of Oral GB001 in Asthma and Chronic Rhinosinusitis
7:40am
DEF 14A
ebzvwb
30 Apr 19
Definitive proxy
4:04pm
DRS
x4uknrz3av
11 Oct 18
Draft registration statement
12:00am
DRS/A
kt3dxvaeckwg8
29 Nov 18
Draft registration statement (amended)
12:00am
424B4
tnry1
8 Feb 19
Prospectus supplement with pricing info
4:40pm
S-1
b3amp2d1 pvv3h
21 Dec 18
IPO registration
4:39pm
S-1/A
cu8fn xo0cwv52gxs
23 Jan 19
IPO registration (amended)
4:39pm
10-K
t8g3k5h7u7f4sp
22 Mar 19
Annual report
4:45pm